ResearcherUniversity of Nebraska Medical CenterActive in the last 2 years
Kasturi Banerjee
Matched on ORCID iD 0000-0002-8803-3602; OpenAlex author ID A5005727548. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 3
- A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer. Co-author DOI 10.1016/j.actbio.2026.04.026↗
- Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition. Co-author DOI 10.1016/j.trsl.2018.12.008↗
- Emerging trends in the immunotherapy of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2017.12.012↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Balaji Narasimhan · 2 shared papers, 2018–2026 · strength 0.31
- Shailendra Kumar Gautam · 2 shared papers, 2018–2026 · strength 0.31
- Surinder K. Batra · 2 shared papers, 2018–2026 · strength 0.31
- Maneesh Jain · 2 shared papers, 2018–2026 · strength 0.31
- Joyce C. Solheim · 2 shared papers, 2018–2026 · strength 0.31
- Aliasger K Salem · 1 shared paper, 2026 · strength 0.24
- Luman Liu · 1 shared paper, 2026 · strength 0.24
- Katie L. Bailey · 1 shared paper, 2019 · strength 0.09
- H. Carlo Maurer · 1 shared paper, 2019 · strength 0.09
- Sushil Kumar · 1 shared paper, 2019 · strength 0.09
- Maher Y. Abdalla · 1 shared paper, 2019 · strength 0.09
- Iman M. Ahmad · 1 shared paper, 2019 · strength 0.09
- Christopher M. Thompson · 1 shared paper, 2019 · strength 0.09
- Kenneth P. Olive · 1 shared paper, 2019 · strength 0.09
- Satyanarayana Rachagani · 1 shared paper, 2019 · strength 0.09
- Brittany J. Poelaert · 1 shared paper, 2018 · strength 0.07
- Rakesh Bhatia · 1 shared paper, 2018 · strength 0.07
- Sushil Kumar K · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.